Showing results (81-90 of 144) with videos related to

Sort By:
Pageof 15
Respiratory Research|December 21, 2024
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for cliniciansKatrin Haeussler, Afisi S Ismaila, Mia Malmenäs, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|July 28, 2012
Frequency of non-asthma GP visits predicts asthma exacerbations: an observational study in general practiceMichael E Hyland, Ben Whalley, David M G Halpin, et al.
Clinical Endocrinology|January 16, 2008
A common intron 2 polymorphism of the glucocorticoid receptor gene is associated with insulin resistance in menAkheel A Syed, Christina G Halpin, Julie A E Irving, et al.
ERJ Open Research|May 12, 2018
Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analysesDavid M G Halpin, Ruby Birk, Noushin Brealey, et al.
American Journal of Respiratory and Critical Care Medicine|December 16, 2024
Is Disease Stability an Attainable Chronic Obstructive Pulmonary Disease Treatment Goal?Dave Singh, MeiLan K Han, Surya P Bhatt, et al.
Pulmonary Therapy|March 18, 2020
Comparative Responses in Lung Function Measurements with Tiotropium in Adolescents and Adults, and Across Asthma Severities: A Post Hoc AnalysisDavid M G Halpin, Eckard H Hamelmann, Peter A Frith, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 10, 2021
Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPDJean Bourbeau, Mona Bafadhel, Neil C Barnes, et al.
Clinical and Translational Allergy|August 28, 2019
Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbationsDavid B Price, Sinthia Bosnic-Anticevich, Ian D Pavord, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|April 30, 2020
Reducing the hidden burden of severe asthma: recognition and referrals from primary practiceMarc Humbert, Arnaud Bourdin, Nikolaos G Papadopoulos, et al.
The Lancet. Global Health|September 16, 2022
The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic reviewMarie Stolbrink, Helen Thomson, Ruth M Hadfield, et al.
Pageof 15